Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
暂无分享,去创建一个
Hisataka Kobayashi | Yoshio Sakai | Peter L Choyke | Satomi Kawamoto | T. Waldmann | P. Choyke | M. Brechbiel | Hisataka Kobayashi | R. Star | N. Sato | S. Kawamoto | Y. Tagaya | Martin W Brechbiel | Y. Sakai | Robert A Star | Noriko Sato | Yutaka Tagaya | John C Morris | Thomas A Waldmann | J. Morris | J. Morris
[1] Michael V Knopp,et al. Comparison of dendrimer‐based macromolecular contrast agents for dynamic micro‐magnetic resonance lymphangiography , 2003, Magnetic resonance in medicine.
[2] H. Moch,et al. Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients? , 2003, Journal of the National Cancer Institute.
[3] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[4] S. Leong. Selective sentinel lymphadenectomy for malignant melanoma. , 2003, The Surgical clinics of North America.
[5] Hisataka Kobayashi,et al. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. , 2003, Cancer research.
[6] Y. Yuan,et al. Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent: Preliminary observations in dongs and humans , 2003, Acta radiologica.
[7] K. Suga,et al. Localization of Breast Sentinel Lymph Nodes by Mr Lymphography With a Conventional Gadolinium Contrast Agent , 2003 .
[8] M. Torchia,et al. Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17. , 2002, AJR. American journal of roentgenology.
[9] E. Morita. Lymphoscintigraphy in the detection of sentinel lymph nodes. , 2002, Cancer treatment and research.
[10] R. Love. Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Torchia,et al. Interstitial MR lymphangiography for the detection of sentinel lymph nodes , 2001, Journal of surgical oncology.
[12] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Aarsvold,et al. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma detecting probe. , 2001, Radiologic clinics of North America.
[14] M. Brechbiel,et al. 3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties , 2001, Magnetic resonance in medicine.
[15] G. Viale,et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. , 2001, European journal of cancer.
[16] M. Brechbiel,et al. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. , 2001, Bioconjugate chemistry.
[17] Piero Musiani,et al. DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2 , 2000, The Journal of Immunology.
[18] D. Reintgen,et al. The role of sentinel lymph node biopsy in breast cancer. , 1999, Journal of the American College of Surgeons.
[19] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[20] E. Winer,et al. Complications of axillary lymph node dissection for carcinoma of the breast , 1998, Cancer.
[21] M. Fan,et al. Lymph node micrometastases from breast carcinoma , 1997, Cancer.
[22] A E Giuliano,et al. Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] T. Waldmann,et al. Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells , 1996, The EMBO journal.
[24] A. Villa,et al. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. , 1992, Cancer letters.
[25] J. Bertrand,et al. Anaphylactic shock induced by intravenous gadopentetate dimeglumine , 1992, The Lancet.
[26] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[27] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[28] C. Redmond,et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.